ArticleJournal of translational medicine2026

TRPML1 agonists synergize with enzyme replacement therapy in fibroblasts from Pompe disease patients.

Carla Damiano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.